Skye Biosci 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
nimacimab (RYI-018) / Skye Biosci
CBeyond, NCT06577090: Study to Evaluate the Effect on Obesity of Once Weekly Nimacimab Injection and Once Weekly Nimacimab Injection Co-administered With Semaglutide Injection Versus Placebo

Active, not recruiting
2
120
US
Nimacimab injection, Nimacimab placebo injection, semaglutide injection
Skye Bioscience, Inc., Bird Rock Bio Sub, Inc.
Obesity
08/25
01/26
ACTRN12617000133336: An Adaptive Design Study for the Assessment of the Safety, Tolerability and Pharmacokinetics of RYI-018 after Single Dosing in Healthy Volunteers and Repeat Dosing in Subjects with Non-Alcoholic Fatty Liver Disease (NAFLD)

Recruiting
1
84
 
Bird Rock Bio Inc, Bird Rock Bio Inc
Non-Alcoholic Fatty Liver Disease
 
 
THC-valine-hemisuccinate (SBI-100) / Skye Biosci
NCT06144918: Phase 2, Placebo-Controlled, Study Assessing the Safety and Ocular Efficacy of SBI-100 Ophthalmic Emulsion in Patients With Elevated Eye Pressure

Completed
2
56
US
SBI-100 Ophthalmic Emulsion, 0.5%, SBI-100 Ophthalmic Emulsion, 1.0%, SBI-100 Ophthalmic Emulsion, Placebo
Skye Bioscience, Inc.
Primary Open Angle Glaucoma, Ocular Hypertension
02/24
02/24
ACTRN12622000971730: A study to evaluate the Safety, Tolerability, and Pharmacokinetics of SBI-100 Ophthalmic Emulsion in Healthy Adult Participants

Completed
1
48
 
Skye Biosciences,Inc., Skye Biosciences,Inc.
Glaucoma
 
 
cannabidiol (NB23R1) / University of Mississippi Medical Center, Skye Biosci
No trials found
cannabidiol valine hemisuccinate (CBDVHS) / Skye Biosci
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
nimacimab (RYI-018) / Skye Biosci
CBeyond, NCT06577090: Study to Evaluate the Effect on Obesity of Once Weekly Nimacimab Injection and Once Weekly Nimacimab Injection Co-administered With Semaglutide Injection Versus Placebo

Active, not recruiting
2
120
US
Nimacimab injection, Nimacimab placebo injection, semaglutide injection
Skye Bioscience, Inc., Bird Rock Bio Sub, Inc.
Obesity
08/25
01/26
ACTRN12617000133336: An Adaptive Design Study for the Assessment of the Safety, Tolerability and Pharmacokinetics of RYI-018 after Single Dosing in Healthy Volunteers and Repeat Dosing in Subjects with Non-Alcoholic Fatty Liver Disease (NAFLD)

Recruiting
1
84
 
Bird Rock Bio Inc, Bird Rock Bio Inc
Non-Alcoholic Fatty Liver Disease
 
 
THC-valine-hemisuccinate (SBI-100) / Skye Biosci
NCT06144918: Phase 2, Placebo-Controlled, Study Assessing the Safety and Ocular Efficacy of SBI-100 Ophthalmic Emulsion in Patients With Elevated Eye Pressure

Completed
2
56
US
SBI-100 Ophthalmic Emulsion, 0.5%, SBI-100 Ophthalmic Emulsion, 1.0%, SBI-100 Ophthalmic Emulsion, Placebo
Skye Bioscience, Inc.
Primary Open Angle Glaucoma, Ocular Hypertension
02/24
02/24
ACTRN12622000971730: A study to evaluate the Safety, Tolerability, and Pharmacokinetics of SBI-100 Ophthalmic Emulsion in Healthy Adult Participants

Completed
1
48
 
Skye Biosciences,Inc., Skye Biosciences,Inc.
Glaucoma
 
 
cannabidiol (NB23R1) / University of Mississippi Medical Center, Skye Biosci
No trials found
cannabidiol valine hemisuccinate (CBDVHS) / Skye Biosci
No trials found

Download Options